MedTech & Diagnostics
Masimo Executive Compensation (FY25)
MASI · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ Catherine Szyman | Median of the other named officers $2,215,518 5 officers, excluding the chief executive | Latest say-on-pay support = April 29, 2025 | Chief executive pay ratio ◇ To the median employee |
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The Masimo brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of October 22, 2026Latest filing (10-K): May 1, 2026
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Member, one year
295 figures on this page: 285 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
Masimo does not file an annual proxy statement (DEF 14A). Its executive compensation is disclosed directly in its Form 10-K (Part III), which is the filing cited throughout this document.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Joe Kiani → Catherine Szyman
Say-on-pay support: 64.9% → 88.1% (23.2 points higher)
CEO pay ratio: 163:1 → 212:1 (30.1% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Masimo's chief executive and what were they paid?
Total compensation for Catherine Szyman, Chief Executive Officer, came to $19,797,140 in fiscal 2025.
What was Masimo's say-on-pay result?
For fiscal 2024, shareholders backed the say-on-pay proposal with 88.1% of votes cast for or against in favor at the meeting held April 29, 2025.
Which companies are in Masimo's peer group?
Companies named in the disclosed peer group include Align Technology, Inc., CONMED Corporation, DENTSPLY SIRONA, Inc., Dexcom, Inc. and Globus Medical, Inc., among others.
What is Masimo's chief executive pay ratio?
The company reported a chief executive pay ratio of 212:1 for fiscal 2025, against median employee compensation of $82,554.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joe Kiani Former Chief Executive Officer and Chairman of the Board | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Bilal Muhsin Chief Operating Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Micah Young Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Tom McClenahan Executive Vice President, General Counsel and Corporate Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Tao Levy Executive Vice President, Business Development | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joe Kiani Former Chief Executive Officer and Chairman of the Board | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Bilal Muhsin Chief Operating Officer | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Micah Young Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Tom McClenahan Executive Vice President, General Counsel and Corporate Secretary | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Tao Levy Executive Vice President, Business Development | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joe Kiani Former Chief Executive Officer and Chairman of the Board Departed during or after this year | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Bilal Muhsin Chief Operating Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Micah Young Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Tom McClenahan Executive Vice President, General Counsel and Corporate Secretary | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Blair Tripodi Chief Operating Officer, Consumer Division | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Michelle Brennan Former Interim Chief Executive Officer Departed during or after this year Served on an interim basis | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Catherine Szyman Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Micah Young Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Charles Dadswell Executive Vice President, General Counsel and Corporate Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Greg Meehan Chief Commercial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Anand Sampath Executive Vice President, Operations | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Michelle Brennan Former Interim Chief Executive Officer Departed during or after this year | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Anand Sampath | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Catherine Szyman | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Catherine Szyman | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Catherine Szyman | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Catherine Szyman | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Catherine Szyman | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Charles Dadswell | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Greg Meehan | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Greg Meehan | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Greg Meehan | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Micah Young | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Micah Young | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Micah Young | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Michelle Brennan | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Michelle Brennan | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Micah Young | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/1/2034 | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/22/2032 | |
| Option | ◇ | — | ◇ | 3/11/2035 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/26/2031 | |
| Option | ◇ | — | ◇ | 3/2/2033 | |
| Michelle Brennan | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Anand Sampath | Option | ◇ | — | ◇ | 2/26/2031 |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/22/2032 | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Catherine Szyman
Chief Executive Officer · Offer letter · dated January 17, 2025
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Equity acceleration on change in control | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Michelle Brennan
Former Interim Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
| Severance base | ◇ |
| Severance cash amount | ◇ |
| Change-in-control base | ◇ |
| Equity acceleration on change in control | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Quentin Koffey | ◇ | ◇ | — | — | — | ◇ | ◇ |
Darlene Solomon | ◇ | ◇ | — | — | — | — | ◇ |
William Jellison | ◇ | ◇ | — | — | — | — | ◇ |
Tim Scannell | ◇ | ◇ | — | — | — | — | ◇ |
Wendy Lane | ◇ | ◇ | — | — | — | — | ◇ |
Robert Chapek | ◇ | — | — | — | — | — | ◇ |
Craig Reynolds | ◇ | — | — | — | — | — | ◇ |
Michelle Brennan and Catherine Szyman served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: Oversee and determine compliance with our stock ownership guidelines;
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Align Technology, Inc. ALGN
- CONMED Corporation CNMD
- DENTSPLY SIRONA, Inc. XRAY
- Dexcom, Inc. DXCM
- Globus Medical, Inc. GMED
- Haemonetics Corp. HAE
- Hologic, Inc. HOLX
- ICU Medical, Inc. ICUI
- Insulet Corporation PODD
- Integer Holdings Corporation ITGR
- LivaNova PLC LIVN
- Merit Medical Systems, Inc MMSI
- Penumbra, Inc. PEN
- QuidelOrtho Corporation QDEL
- Teleflex, Inc. TFX
- The Cooper Companies, Inc. COO
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2024 | April 29, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | September 19, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 26, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 26, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 27, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 29, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 30, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 31, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | June 1, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | April 20, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Velarion Pro: every company page, peer tools and exports, one seat
One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Catherine Szyman (Chief Executive Officer), FY2025 total compensation $19,797,140 (base salary $850,048) [exec_comp, SEC accession 0001104659-26-054180, filed 2026-05-01]What this page does not include
Everything above is a fact Masimo disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Masimo sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
295 figures on this page: 285 cited to the filing that reported them, 10 calculated from figures it prints.
285 cited to the filing
10 calculated from the filing
Documents cited
- 0001104659-26-054180
- 0001104659-25-042485Proposal No. 3 : To provide an advisory vote to approve the compensation of the Company’s named executive officers.
- 0001104659-25-027887Compensation Discussion and Analysis · Summary Compensation Table
- 0000937556-25-000007EX-10.1
- 0000937556-24-000085Proposal No. 3 : To provide an advisory vote to approve the compensation of the Company’s named executive officers.
- 0001213900-24-053125Summary Compensation Table
- 0000937556-23-000172Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000937556-22-000107Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000937556-21-000105Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000937556-20-000119Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000937556-19-000112
- 0000937556-18-000102Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000937556-17-000132Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000937556-16-000263Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Masimo executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/MASI (accessed 2026).
Short form: data: Velarion
The Masimo brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Masimo and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers Masimo discloses
The companies named in MASI's own disclosed peer group.
Align Technology, Inc.CONMED CorporationDENTSPLY SIRONA, Inc.Dexcom, Inc.Globus Medical, Inc.Haemonetics Corp.Hologic, Inc.ICU Medical, Inc.Insulet CorporationInteger Holdings CorporationLivaNova PLCMerit Medical Systems, IncPenumbra, Inc.QuidelOrtho CorporationTeleflex, Inc.The Cooper Companies, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}